TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PHAT

Phathom Pharmaceuticals Inc

Healthcare · Biotechnology

7.00$ -10.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PHAT
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 99.4% 98.7% 98.5% 97.4% 96.0% 95.2% 88.4%
97.5% 94.8% 97.4% 96.7% 94.3% 92.2% 78.6% 50.2%
97.5% 94.8% 97.4% 96.7% 94.3% 92.2% 78.6% 50.2%
0.0% 0.0% 0.4% 10.3% 30.1%
0.0% 0.0% 0.3% 0.8% 2.1%
0.5% 1.1% 0.3% 2.1%
242.6% 11.4% 34.2% 61.9% 145.4% 117.6% 167.0% 269.1%
242.6% 1.5% 18.8% 10.0% 15.9% 9.4% 22.7% 51.0%
216.2% 0.1% 2.7% 0.3% 0.4% 0.2% 0.1% 0.3%
6.1% 0.3% 5.7% 2.7% 6.1% 3.0% 2.8% 1.9%
8.9% 13.4% 47.3% 57.8% 33.3% 53.2% 80.7%
-142.6% 88.6% 65.8% 38.1% -45.4% -17.6% -67.0% -169.1%
-142.8% -99.7% -130.6% -279.5% -441.2% -224.4% -333.8% -572.7%
951.0% 9.6% 11.3% 19.5% 23.7% 12.4% 16.7% 28.1%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?